Multi-national studies call for informed approach: Firma Clinical Research
An expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them.
Archives for January 25, 2022
FDA approves IND for clinical trial evaluating CBD-based drug
The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientific’s Nantheia ATL5, a candidate for treating opioid use disorder.